- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Adult Hepatocellular Carcinoma in Hong Kong
Total 179 results
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
SCG Cell Therapy Pte. Ltd.RecruitingHepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular CarcinomaUnited States, Singapore, Hong Kong
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
PfizerCompletedCarcinoma, HepatocellularKorea, Republic of, China, Taiwan, Hong Kong
-
Chinese University of Hong KongCompletedHIV Infections | Hepatitis B | Hepatocellular Carcinoma | Hepatitis CHong Kong
-
Chinese University of Hong KongHenan Provincial People's HospitalCompletedHepatitis B | Hepatocellular CarcinomaChina
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
Arbutus Biopharma CorporationCompletedHepatocellular Carcinoma | Hepatoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultUnited States, Taiwan, Singapore, China, Canada, Korea, Republic of
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, United States, Hong Kong
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, Thailand, Hong Kong
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsTaiwan, Hong Kong, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular CarcinomaTaiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
-
Ligand PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Canada, Australia, Hong Kong, Korea, Republic of
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, China, Japan
-
Omega TherapeuticsRecruitingHepatocellular Carcinoma | Solid Tumor | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Recurrent | Liver, Cancer of, Non-ResectableUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Astellas Pharma Global Development, Inc.PfizerCompletedAdvanced Hepatocellular CarcinomaCanada, United States, Hong Kong, Italy, Korea, Republic of, Puerto Rico, Spain, Taiwan, United Kingdom
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
AstraZenecaRecruitingAdvanced Hepatocellular CarcinomaKorea, Republic of, Italy, Spain, Vietnam, Germany, France, Japan, United States, Hong Kong, Singapore
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationTerminatedCancer | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, Taiwan, Hong Kong, China
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaChina, Taiwan, Thailand, Korea, Republic of, Hong Kong
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
TularikUnknownHepatocellular CarcinomaUnited States, China
-
GC Cell CorporationCompletedHepatocellular CarcinomaKorea, Republic of
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Proacta, IncorporatedTerminatedHepatocellular CarcinomaUnited States, Taiwan, Singapore, Hong Kong
-
Bristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultChile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
-
AstraZenecaCompletedHepatocellular CarcinomaKorea, Republic of, Russian Federation, Hong Kong, Egypt, Saudi Arabia, United Arab Emirates, Singapore, India, Kuwait, Oman, Brazil
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaTaiwan, Hong Kong, China, Thailand, Korea, Republic of, Singapore, Japan
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
Singapore General HospitalNational Cancer Centre, Singapore; National Medical Research Council (NMRC)... and other collaboratorsUnknownHepatocellular CarcinomaTaiwan, Korea, Republic of, Malaysia, New Zealand, Philippines, Singapore, China, Thailand, Brunei Darussalam, Indonesia, Mongolia, Myanmar
-
Bristol-Myers SquibbCompletedHepatocellular Carcinoma (HCC)France, Korea, Republic of, Taiwan, United States, Singapore, Philippines, Malaysia, Hong Kong
-
National Cancer Centre, SingaporeIqvia Pty Ltd; Singapore Clinical Research Institute; Asia-Pacific Hepatocellular...CompletedHepatocellular CarcinomaChina, Korea, Republic of, Taiwan, Australia, Hong Kong, Singapore, New Zealand, Japan, Thailand
-
FeRxTerminatedCarcinoma, HepatocellularUnited States, Austria, Thailand, Germany, Ukraine, United Kingdom, Hong Kong, Russian Federation
-
BayerCompletedCarcinoma, HepatocellularJapan, Turkey, Austria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Switzerland, India, Korea, Republic of, France, Mexico, Indonesia, Singapore, Thailand, Canada, Greece, Netherlands, Spain, Taiwan, Poland, Brazil, China, D... and more
-
ImunonCompletedHepatocellular CarcinomaKorea, Republic of, China, Hong Kong, Singapore, Thailand, Malaysia, United States, Canada, Taiwan, Spain, Philippines, Germany, Italy, Vietnam
-
Novartis PharmaceuticalsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Renal Cancer | Hepatocellular CancerTaiwan, Germany, Italy, Austria, Switzerland, Hong Kong, Japan, Canada, United States
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
MedImmune LLCActive, not recruitingHepatocellular CarcinomaUnited States, Italy, Spain, Taiwan, Korea, Republic of, China, Hong Kong, Japan, Singapore
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsPhilippines, Korea, Republic of, Singapore, Sweden, Malaysia, India, Serbia, Thailand, Croatia, Hong Kong, Poland
-
SC Liver Research Consortium, LLCBayerTerminated
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingLocally Advanced Nasopharyngeal CarcinomaChina
-
Shenzhen People's HospitalSixth Affiliated Hospital, Sun Yat-sen University; The University of Hong Kong-Shenzhen...RecruitingLocally Advanced Rectal CarcinomaChina